NCI Drug Dictionary
The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer. Each drug entry includes links to check for clinical trials listed in NCI's List of Cancer Clinical Trials.
- methylmercaptopurine riboside
-
A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation. Check for active clinical trials using this agent. (NCI Thesaurus)
Synonym: methylthioinosine Abbreviation: 6-MMPR
MMPRCode name: NCI-C04784
SQ 21977Chemical structure: - 6-(methylmercapto)purine ribonucleoside
- 6-(methylthio) inosine
- 6-(methylthio)purine ribonucleoside
- 6-(methylthio)purine riboside
- 6-methyl MP riboside
- 6-methylmercaptopurine riboside
- 6-methylthioinosine
- 9H-purine, 6-(methylthio)-9beta-D-ribofuranosyl
- 9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl- (8CI 9CI)
- 9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl-, dihydrate
- beta-D-ribosyl-6-methylthiopurine
- purine-6-thiol,6-methyl-9-ribofuranosyl